The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT Substudy
EuroIntervention 2018;13:1923-1930 published online November 2017. DOI: 10.4244/EIJ-D-17-00792
1. Division of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea; 2. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea; 3. Dankook Universit
Aims: There are few randomised studies concerning the optimal duration of dual antiplatelet therapy (DAPT) for patients who receive a second-generation drug-eluting stent (DES). This tria